Eva. V. Vodegel

Eva. V. Vodegel

Auto-generated profile, based on publicly available information

Eva. V. Vodegel

Department of Obstetrics and Gynaecology Amsterdam University Medical Centre – Location AMC, University of Amsterdam Amsterdam the Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2021 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
PDF file
CDChantal M. Diedrich
Chantal M. Diedrich
ZGZeliha Guler
Zeliha Guler
LHLucie Hympanova
Lucie Hympanova
EVEva Vodegel
Eva Vodegel
MZManuel Zündel
Manuel Zündel
JRJan Paul Roovers
Jan Paul Roovers
Objective: To evaluate the host‐ and biomechanical response to a fully absorbable poly‐4‐hydroxybutyrate (P4HB) scaffold in comparison with the response to polypropylene (PP) mesh.Design: In vivo animal experiment.Setting: KU Leuven Center for Surgical Technologies.Population: Fourteen parous female Mule sheep.Methods: P4HB scaffolds were surgically implanted in the posterior vaginal wall of sheep. The comparative PP mesh data were obtained from an identical study protocol performed previously.Main outcome measures: Gross necropsy, host response and biomechanical evaluation of explants, and the in vivo P4HB scaffold degradation were evaluated at 60‐ and 180‐days post‐implantation. Data are reported as mean ± standard deviation (SD) or standard error of the mean (SEM).Results: Gross necropsy revealed no implant‐related adverse events using P4HB scaffolds. The tensile stiffness of the P4HB explants increased at 180‐days (12.498 ± 2.66 N/mm SEM [p =0.019]) as compared to 60‐days (4.585 ± 1.57 N/mm) post‐implantation, while P4HB degraded gradually. P4HB scaffolds exhibited excellent tissue integration with dense connective tissue and a moderate initial host response. P4HB scaffolds induced a significantly higher M2/M1 ratio (1.70 ± 0.67 SD, score 0–4), as compared to PP mesh(0.99 ± 0.78 SD, score 0–4) at 180‐days.Conclusions: P4HB scaffold facilitated a gradual load transfer to vaginal tissue over time. The fully absorbable P4HB scaffold, in comparison to PP mesh, has a favorable host response with comparable load‐bearing capacity. If these results are also observed at longer follow‐up in‐vivo, a clinical study using P4HB for vaginal POP surgery may be warranted to demonstrate efficacy.Tweetable Degradable vaginal P4HB implant might be a solution for treatment of POP.

13 October 2021 in Neurourology and Urodynamics
Verified
Journal Article
Open access
PDF file
EVEva V. Vodegel
Eva V. Vodegel
AKArnoud W. Kastelein
Arnoud W. Kastelein
CJCharlotte H. J. R. Jansen
Charlotte H. J. R. Jansen
JLJacqueline Limpens
Jacqueline Limpens
SZSandra E. Zwolsman
Sandra E. Zwolsman
ZGZeliha Guler
Zeliha Guler
Aims: To determine the effects of oestrogen or oestrogen deprivation on vaginal wound healing. Impaired wound healing following prolapse surgery may increase the risk of recurrent prolapse in the future. Vaginal oestrogen therapy may improve wound healing, hereby possibly improving surgical outcomes.Methods: A systematic search of OVID MEDLINE, OVID Embase, and Web of Science was conducted up to January 28, 2020. We included original studies comparing wound healing‐related outcomes of oestrogen exposed subjects (female animals and women) to hypo‐oestrogenic subjects after vaginal surgery. Data on wound healing‐related outcome measures were extracted. For each individual comparison, the standardised mean difference (Hedges' g; SMD) and 95% confidence interval (CI) were calculated.Results: Of the 1474 studies reviewed, 14 studies were included for review, and 11 provided data for meta‐analysis. Oestrogen improves neovascularisation (SMD: 1.13, 95% CI: 0.67–1.60), microscopic wound closure (SMD: 0.98, 95% CI: 0.66–1.29), collagen synthesis (SMD: 1.08, 95% CI: 0.42–1.74), and tissue strength (SMD: 1.26, 95% CI: 0.53–1.99) in animals. Oestrogen increases granulation (SMD: 1.67, 95% CI: 0.54–2.79) and accelerates macroscopic wound closure (SMD: 1.82, 95% CI: 1.22–2.42) in women and animals. Oestrogen decreases the inflammatory response (SMD: −0.58, 95% CI: −1.14 to −0.02) in women and animals and reduces levels of transforming growth factor (TGF)‐β1 (SMD: −1.68, 95% CI: −2.52 to −0.83) in animals. All results were statistically significant.Conclusions: Oestrogen therapy has a positive effect on vaginal wound healing. Future studies should determine whether oestrogen therapy has the potential to improve surgical outcomes.

5 October 2020 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
KMKaterina Mackova
Katerina Mackova
AMAnna Marie Mazzer
Anna Marie Mazzer
MCMarina Gabriela Monteiro Carvalho Mori Da Cunha
Marina Gabriela Monteiro Carvalho Mori Da Cunha
LHLucie Hajkova Hympanova
Lucie Hajkova Hympanova
IUIva Urbankova
Iva Urbankova
JDJan Deprest
Jan Deprest

29 March 2022 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
EVEva V. Vodegel
Eva V. Vodegel
KDKim W. M. van Delft
Kim W. M. van Delft
CNCharlotte H. C. Nuboer
Charlotte H. C. Nuboer
CKClaudia R. Kowalik
Claudia R. Kowalik
JRJan‐Paul W. R. Roovers
Jan‐Paul W. R. Roovers
Objective: To analyse the efficacy of sacrospinous ligament (SSL) suture removal on the reduction of pain symptoms in the case of suspected pudendal nerve entrapment after sacrospinous ligament fixation (SSLF).Design: Retrospective cohort study.Setting: Tertiary referral centre, the Netherlands.Population: A cohort of 21 women having their SSLF sutures removed because of SSLF‐related pain symptoms.Methods: Clinical record review.Main outcome measures: The primary outcome was reduction of pain after SSL suture removal. Secondary outcome measures were time interval between suture placement and suture removal, complete suture removal, adverse events and recurrence of pelvic organ prolapse (POP).Results: A total of 21 women underwent SSL suture removal for severe and/or persistent pain, which was confirmed on clinical examination: 95% of the women (20/21) reported pain reduction after suture removal, and 57% reported complete pain relief. The time interval between suture placement and suture removal was at a median of 414 days (range 8–1855 days). Sutures could be completely removed in 86% of cases (18/21). One woman had excessive blood loss (520 ml) without blood transfusion. At 6–8 weeks after surgery, 10% of the women (2/21) had renewed symptomatic POP, stage ≥ 2, for which additional POP surgery was indicated.Conclusions: When performed by an experienced clinician, SSL suture removal is feasible and efficacious, with low morbidity. In addition, the risk of recurrent POP in the short term appeared to be low.Tweetable The surgical removal of sacrospinous ligament sutures is safe and efficacious for pain relief, even remote from initial placement.

7 May 2023 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
EVEva V. Vodegel
Eva V. Vodegel
ZGZeliha Guler
Zeliha Guler
LRLamees Ras
Lamees Ras
KMKaterina Mackova
Katerina Mackova
AGAnne C. H. M. Groeneveld
Anne C. H. M. Groeneveld
JRJan‐Paul W. R. Roovers
Jan‐Paul W. R. Roovers
Objective: To evaluate the effect of iatrogenic menopause on the physiology of the vagina of the ewe and to evaluate if vaginal changes in ewes can be translated to women with genitourinary syndrome of menopause (GSM).Methods: Preclinical research with Dohne Merino ewes. Iatrogenic menopause was induced by bilateral ovariectomy (OVX). Animals were randomized for surgery, blinded for allocation and outcome assessment. Differences between groups were determined by linear regression analyses at 5 months after OVX. Outcome measures were vaginal epithelial thickness, pH, vaginal maturation value, vaginal maturation index, epithelial glycogen accumulation, content of elastin fibers, collagen, and vascularity.Results: OVX ewes (n = 20) showed epithelial thinning of the vaginal wall from 146 μm to 47 μm (mean, P < 0.001). Furthermore, epithelial glycogen accumulation and vascularity of the vaginal wall significantly decreased (43% and 23%, respectively) as compared with the control group (no intervention; n = 5). No significant differences were found for other outcome measures.Conclusion: This study established the ewe as a suitable large animal model for GSM. Furthermore, the similar relevant outcomes in humans and ewes hold great value for future translational research for the evaluation and optimization of different treatment modalities for GSM.

SAS. Anglès-Acedo
S. Anglès-Acedo
LLLorena López-Frías
Lorena López-Frías
VSVicenç Soler
Vicenç Soler
JAJoan Francesc Alonso
Joan Francesc Alonso
AKArnoud Kastelein
Arnoud Kastelein
OCon behalf of the WOMEN-UP Consortium
on behalf of the WOMEN-UP Consortium
E-Health may enhance self-management of pelvic floor muscle training (PFMT) to treat stress urinary incontinence (SUI). It is crucial to involve patients in planning, developing and monitoring the optimal e-Health solution. This research aims to describe patient-centered innovation in an early developmental stage of the WOMEN-UP solution. We conducted a qualitative study through a self-developed questionnaire in 22 women with SUI, to define system requirements from a patient’s perspective. The first prototype of the WOMEN-UP solution was developed. It was tested by 9 patients in a usability study (think-aloud protocol and retrospective interviews). Patient preferences regarding the possible use of an e-Health solution with serious games for PFMT were: (1) to receive feedback about PFMT; (2) convenient home-use; (3) increasing motivation; (4) available in medical centers. Identified usability aids (31) reassured our design-development plan, which considered the biofeedback and serious games as key factors. Patient’s perspective detected some unexpected issues related to the calibration and serious games, involving a change in the ongoing development to get an improved WOMEN-UP solution; the value of patient-centered innovation during the development of an e-Health solution for PFMT (WOMEN-UP solution). To identify patients’ unmet needs, we proposed a longitudinal approach for the future eHealth-related patient-centered innovations.